WAT vs XRAY
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 01, 2026
WAT
XRAY
Investment Advisor Scores
XRAY
AI Analyst Insights
Detailed Metrics Comparison
| Metric | WAT | XRAY | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 24.7525 | 6.3291 | XRAY |
| PEG Ratio | 1.5658 | 0.633 | XRAY |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 113.4% | -4.1% | WAT |
| Earnings Growth | -3.1% | 15.2% | XRAY |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 38.6/100 | 48.1/100 | XRAY |
| Profit Margin | 3.6% | -15.0% | WAT |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
WAT
MarkupPrice above SMA50, rising 50-day trend (4.9% over 20 days), RSI 53
XRAY
MarkdownPrice below a falling SMA50 (slope -7.5%), weak momentum, RSI 28
Fundamentals Snapshot
| Metric | WAT | XRAY |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 25.7 | 5.8 |
| Trailing P/E | 111.2 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 1.1% | 0.0% |
| Gross Margin | 0.6% | 0.5% |
| Operating Margin | 0.1% | 0.1% |
| EPS | 3.95 | -2.69 |
| Dividend Yield | — | 0.04% |